Sign in to view content

Progression of glaucoma after anti-VEGF injections in susceptible eyes- Dr. Eugene Shildkrot

Keyvan Koushan, MD, FRCSC

Audio
Published 2020

Related

First Results From a Phase 1B Multiple-Dose Study of KSI-301: A Novel Anti-VEGF Antibody Biopolymer Conjugate (ABC) With Extended Durability
Pravin U. Dugel, MD
Annual Meeting Talks
2019
Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema
Chirag D. Jhaveri, MD, FASRS
Updates from the Field
2022
Wet AMD 6 Symposium
Annual Meeting Talks
2020

Category: Pharmacology-AntiVEGF

See more